中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2013, Vol. 48 Issue (18) :1602-1603    DOI: 10.11669/cpj.2013.18.023
ҩ�¹��� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
����ר��ҽԺ�걨����ҩ���ٴ���������ʸ��϶�����
���棬����÷�����
�׶�ҽ�ƴ�ѧ������������ҽԺ���д�������100026
LIU Zhen, DAI Yin-mei, LI Jian
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Department of Scientific Research Management,Beijing 100026,China

Download: PDF (0KB)   HTML (1KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ��Ϊר��ҽԺ�걨����ҩ���ٴ���������ṩ������������Ĺ��ҹ���ҩ���ٴ���������ʸ��϶�����ع涨�����ר��ҽԺ���ص㡢����ר��ҽԺ�������ʸ��϶������е�ʵ�ʲ�������ᡣ��������ר��ҽԺ�걨����ҩ���ٴ���������������������ƣ��ھ��ٴ�������Դ��ǿ������רҵ�����������ⲿ��Դ���ֲ������㡣
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
����
����÷
���
�ؼ����� ҩ���ٴ�����   �ʸ���֤   ר��ҽԺ     
Abstract�� OBJECTIVE To provide some references for speciaslized hospital to apply for national drug clinical trial institution. METHODS According to the state on related clinical test qualification of the relevant provisions, combined with the characteristics of specialist hospitals, we described in the application process of qualification and experience of the actual operation. RESULTS AND CONCLUSION Specialized hospital should understand our own weaknesses, mining clinical advantages of resources, strengthen professional advantages, with rational use of external resources in order to make up for our lack.
Keywords�� drug clinical trial,   qualification,   special hospital     
�ո�����: 2013-02-07;
ͨѶ���� ��ᣬŮ������ҽʦ�����ڣ���ʿ����ʦ�о�����ҽԺ���������Ʋ����ٴ��о�Tel(010)85985110     Email: gpm_1994@sohu.com
���߼��: ���棬Ů��������ҩʦ�о�����ҩ���ٴ�����
���ñ���:   
����, ����÷, ��� .����ר��ҽԺ�걨����ҩ���ٴ���������ʸ��϶�����[J]  �й�ҩѧ��־, 2013,V48(18): 1602-1603
LIU Zhen, DAI Yin-Mei, LI Jian .Practice and Approach of Applying for Accreditation of National Drug Clinical Trial Institution by Specialized Hospitals[J]  Chinese Pharmaceutical Journal, 2013,V48(18): 1602-1603
��
[1] XIE Q. Brief description of the current organizational construction of drug clinical trial institutes in China. Chin J Clin Pharmacol(�й��ٴ�ҩ��ѧ��־),2007,23(5):397-400. [2] Focal problems of drug clinical trial in China . China Prescription Drug(�й�����ҩ),2009,4(85):35-38. [3] YU S H. Practice and approach of special hospital on developing. Chin Hosp Manage(�й�ҽԺ����), 2007,27(1):52-53. [4] BAI C Z,WANG C,ZHAO Z G,et al. Strengthen recgnition of ethical review committees and improve the reviewing quality. Chin Pharm J(�й�ҩѧ��־),2011,46(22):1771-1772. [5] LIU S L, WANG X Q,XIONG N N, et al. Ethic review in clinical research: Women and pregnant women . Chin J Clin Pharmacol Therapeut(�й��ٴ�ҩ��ѧ������ѧ),2006,11(4):477-480. [6] HONG M H. Preliminary exploration on the building of clinical trial institutions. China Prescription Drug(�й�����ҩ),2010,6(99):10-11. [7] QUAN J X, ZHAO M, SHAN A L. Function and existing some problem of contract research organization in clinical trial. Chin J Clin Pharmacol(�й��ٴ�ҩ��ѧ��־),26(7):549-551. [8] Good Clinical Practice. SFDA. . http://www. sda. gov. cn/WS01/CL0053/24473. html. [9] On the issuance of the notice of the clinical trials of drugs accreditation odies (Trial). . SFDA. . http://www. sda. gov. cn/WS01/CL0058/9346. html. Drug Registration. SFDA. . http://www. sda. gov. cn/WS01/CL0053/24529_1. html. Declaration of Helsinki(V2008) . The 59th WMA. . http://baike. baidu. com/view/1031580. html. QIU R Z. International organizations of medical sciences(CIOMS) international ethical guidelines for biomedical research involving human subjects. Chin Med Ethics(�й�ҽѧ����ѧ),2002,16(4):20-21. Harmonized Tripartite for Guideline for GCP. 1997, ICH. E6.. http://wenku. Baidu. com/view/386445c69ec3d5bbfd0a7467 html.
Copyright 2010 by �й�ҩѧ��־